相关实验视频
Updated: Jan 17, 2026

06:01
Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
1.3K
克鲁茨菲尔特-雅各布病最初的躁狂表现:一个病例报告
Fatima Ghazi Alotaibi1,2, Rakan Bahammam1, Khalid M Alqarni1
1Department of Neurology, King Saud University Medical City, Riyadh, Saudi Arabia.
The American journal of case reports
|September 22, 2025
概括
躁狂可以是克鲁茨菲尔特-雅各布病 (CJD) 的早期,不常见的症状,这是致命的性障碍. 这一案例凸显了诊断方面的挑战,以及在出现新精神病症状和快速衰退的老年人中需要广泛差异化.
科学领域:
- 神经学 神经学
- 子疾病是子疾病.
- 精神病学是一个精神病学.
背景情况:
- 克鲁茨菲尔特-雅各布病 (CJD) 是一种罕见的,致命的神经退行性疾病,由错误折叠的蛋白引起.
- 典型的CJD呈现出快速进展的痴呆症和神经衰退.
- 精神病症状是常见的早期症状,但作为主要表现的躁狂非常罕见.
研究的目的:
- 报告一个罕见的克鲁茨菲尔特-雅各布病 (CJD) 病例,最初呈现躁狂症状.
- 突出CJD非典型初始呈现所带来的诊断挑战.
- 强调在老年人新发精神症状的差异诊断中考虑CJD的重要性.
主要方法:
- 一个65岁的妇女的病例报告,最初出现躁狂症状.
- 诊断调查包括大脑MRI,EEG和脑脊液分析.
- 脑脊液分析使用实时震动诱导转换 (RT-QuIC) 来检测蛋白.
主要成果:
- 患者最初出现了躁狂症状,包括情绪升高和失眠.
- 神经系统逐渐恶化,出现幻觉和运动衰退.
- 在MRI上观察到CJD的特征性发现 (皮质皮带,基底腺节变化) 和EEG (周期性尖波复合物).
- RT-QuIC证实了子蛋白的存在,从而诊断出偶发性CJD (sCJD).
结论:
- 躁狂可以是克鲁茨菲尔特-雅各布病的非典型早期表现.
- 这个案例强调了当精神病症状主导着CJD的初始表现时,诊断的困难.
- 早期考虑CJD对于准确诊断至关重要,特别是在老年人中,与精神症状一起出现快速的认知或运动衰退.
相关概念视频
Aneurysm II: Clinical Manifestations and Diagnostic Studies
303
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
303
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

